Introduction
Amyloid beta (A ) peptides (39-43 amino acids in length) result from secretase-driven proteolytic processing of the amyloid precursor protein and are the major peptide components of senile plaques. 1, 2 The formation of these insoluble A deposits in the human brain is the pathological hallmark of Alzheimer's disease (AD) . Although the precise reason for the formation of senile plaques in AD remains to be determined, the role of metal ions in promoting the aggregation of A peptides in Vitro has led to debate and extensive research addressing how metals bind to and induce aggregation of A peptides. [3] [4] [5] [6] [7] [8] [9] In particular, elevated concentrations of copper have been measured in the senile plaques, 10, 11 and the use of high-affinity metal ion chelators facilitates the dissolution of these plaques. [12] [13] [14] This knowledge has provided momentum for the development of metal-chelation-based therapies targeted toward treating AD.
Different from humans and numerous other mammals, rats and mice rarely form such plaques with age, despite the fact that rodents produce A peptides in much the same manner as humans. 15, 16 In vitro, the presence of Cu 2+ significantly increases the aggregation of human A (40), but this effect is much less profound for rat A (40). 12 The defining difference, relative to human A , is the presence of three specific substitutions in the primary amino acid sequence of the rat A cleavage product: R5G, Y10F, and H13R. 17 All three mutations lie within the hydrophilic N-terminal, which is also the domain where Cu 2+ binds. The changes between the human and rat peptides are hypothesized to alter the metal binding in a manner that inhibits Cu 2+ -induced aggregation and, subsequently, neurotoxicity. 12, 18 It has been suggested that rat A fragments (e.g., 1-6, 1-10 residues) bind to Cu 2+ more strongly than the corresponding human A fragments over a wide range of solution pH. 19 In line with that work, the current paper finds that the binding constants of Cu 2+ to rat A are about 3 times higher than those of human A peptides at pH 7.4, 37°C, and are similar at pH 6.5. This result suggests, under similar conditions, at pH 7.4-6.5, rat A can bind at least the same amount of Cu 2+ as the human peptide. Because Cu 2+ -induced aggregation is more profound for human A (40), 12 the differences between Cu 2+ coordination spheres between the rat and human peptides must influence the aggregation process. The binding sites for Cu 2+ to human A peptides have been extensively studied with various techniques, including EPR, NMR, CD, Raman, and potentiometry. 4, 5, 9, [19] [20] [21] [22] [23] [24] [25] [26] [27] The Cu 2+ coordination to A has been discussed in a recent review. 28 At physiological pH (∼7.4), Cu 2+ is coordinated by four ligands, 3N and 1O, 4, 5, 9, 19, 21, 22, [24] [25] [26] [27] with evidence that His6, His13, and His14 are involved, along with possible contributions from Tyr10, the carboxylate group of Asp1, the amide CdO of Ala2, and the N-terminus amine. 4, 5, 9, [19] [20] [21] [22] [23] [24] [25] However, the studies to date differ on the exact coordinating ligands. The different experimental conditions (e.g., low temperature compared to room temperature) and different sensitivity of the techniques used for certain binding motifs contribute to the conclusions that had been made. The different models proposed will be discussed in † Abbreviations: A , amyloid beta peptide; AD, Alzheimer's disease; ITC, isothermal titration calorimetry; CD, circular dichrosim; EPR, electron paramagnetic resonance; PIPES, 1,4-piperazinediethanesulfonic acid; HEPES, N-(2-hydroxyethyl)piperazine-N′-(2-ethanesulfonic acid); TEEN, N,N,N′,N′-tetraethylethylenediamine; Chol, (2-aminoethyl)trimethylammonium chloride hydrochloride; His, histidine; Gly, glycine; Arg, arginine; H6, coordination {NH 2 detail later within the context of the conclusion drawn from the current study. Herein, we demonstrate that ITC, combined with CD and EPR, can provide a powerful approach for elucidating details of the coordinating ligands. The data further reveal a novel and interesting correlation between the binding geometry of Cu 2+ and the propensity for Cu
2+
-induced aggregation of human and rat A .
Experimental Section
Materials. Synthetic A peptidesshuman A (16), human A (40), rat A (40), mutants of human A (16) (H6A, H13A, H14A, H6AH13A, H6AH14A, H13AH14A, Y10F, and H13R), Ac-A (16), and mutants of rat A (16) (rat H14A and rat H6A)swere purchased from Bio-Synthesis, Inc. (Lewisville, TX) at >95% purity as custom peptides. Rat A (16) and human R5G mutants were purchased from Department of Physiology, Tufts University, at purity >98%. The sequences of the peptides are listed in Table 1 . Glycine, 1,4-piperazinediethanesulfonic acid (PIPES), and CuCl 2 · (H 2 O) 2 were purchased from SigmaAldrich (St. Louis, MO) at the highest purity grade available.
N-(2-Hydroxyethyl)piperazine-N′-(2-ethanesulfonicacid)(HEPES),
(2-aminoethyl)trimethylammonium chloride hydrochloride (Chol), N,N,N′,N′-tetraethylethylenediamine (TEEN), NaOH, and NaCl (for buffer preparation) were purchased from Fisher Scientific (Waltham, MA) at the highest purity grade available. All solutions were prepared in ultrapure water (>18 MΩ · cm) purified using a Millipore Simplicity system (Billerica, MA).
A (16) and its mutant stock solutions were prepared by dissolving the lyophilized synthetic peptide into ultrapure water (∼5 mg/mL) at room temperature upon receipt of the purified peptide. The peptide stock solutions were then sonicated for ∼2 min in a water bath and centrifuged at 10 000g for 10 min to remove any large aggregates from the lyophilization process. The supernatants were carefully aliquoted into multiple tubes and frozen at -20°C until experimental use. Our previous knowledge showed that, with the presence of an excess amount of glycine, one A (16) peptide molecule only binds to one Cu 2+ at pH 7.4, 37°C. Thus, peptide concentrations were determined with preliminary ITC run by setting the concentration of peptide to get a 1:1 binding stoichiometry when performing data analysis. A (40) solutions were prepared freshly from lyophilized synthetic peptide for each ITC measurement. Briefly, two tubes of ∼0.6 mg of peptide were first suspended in 100 µL of 1 mM NaOH and then 1 mL of buffer separately. After being vortex-mixed thoroughly, the solutions were sonicated at room temperature for 2 min and then centrifuged at 10 000g for 10 min to sediment possible aggregated A (40). The soluble peptide fractions of the two tubes were then combined and diluted to 2.3 mL, which was ready for degassing, pH checking, and ITC measurements. The concentration was determined with Bradford assay (Pierce Biotechnology, Rockford, IL) and adjusted when fitting the ITC data. All buffer stock solutions were prepared at concentrations of 20 mM, with ionic strength adjusted to 160 mM by NaCl, titrated to desired pH at 37°C using 1 M NaOH or 1 M HCl, treated with Chelex100 overnight, and finally filtered through a 0.22 µm cellulose membrane to remove any biological contamination or large particulate matter. A Cu 2+ stock solution was prepared in each buffer using CuCl 2 · (H 2 O) 2 with 4 equiv of glycine in order to prevent the precipitation of Cu(OH) 2 at physiological pH and with 2 equiv of NaOH in order to neutralize the protons released from glycine when it binds to Cu 2+ . Isothermal Titration Calorimetry (ITC). ITC experiments were carried out on a Microcal VP-ITC (Northampton, MA) ultrasensitive microcalorimeter. All solutions were degassed under vacuum at 37°C for 15 min prior to use. The reaction cell contained ∼60 µM peptide in buffer (20 mM, 160 mM ionic strength, pH 7.4, 37°C). The ligand solution, ∼700 µM CuCl 2 with 4 equiv of glycine, contained in the injection syringe, was also diluted in a matching buffer solution identical to the reaction cell. Titrations were performed at 37°C and pH 7.4 or 6.5. The pH of each prepared solution was checked and adjusted, if necessary, after degassing at 37°C to minimize unwanted heats of dilution arising from buffer ionization. A control titration of glycine into peptide for each of the peptides showed that glycine was not interacting with any of the peptides to produce a detectable heat signal (data not shown). No visible precipitate or significant aggregation was observed at the end of each experiment.
ITC data analysis was performed using Igor Pro (Wavemetrics, Lake Oswego, OR) and Origin 7.0 (Northampton, MA) software. The binding constant K and enthalpy ∆H were determined by fitting ITC data using previously developed methods in which the competition of glycine to Cu 2+ was explicitly taken into account. 29, 30 Aggregation Assay. The effects of Cu 2+ on the aggregation of human A (40), rat A (40), and the R5G mutation on human A (40), R5G(40), were examined following the procedures developed by Atwood et al. 12 In brief, ∼2.5 µM peptide in 20 mM HEPES solution (pH 6.5 or 7.4) was incubated with or without CuCl 2 at 37°C for 30 min. The solution was subsequently subjected to centrifugation at 10 000g for 30 min to sediment the aggregates. The concentration of peptide in the supernatant was determined by the Micro Bradford Assay. Duplicate runs were performed for each condition, and the deviations between runs were within 20%.
Circular Dichrosim Spectroscopy (CD). CD spectra were recorded on an Aviv model 202 CD spectrophotometer in the 760-400 nm range with a 2 nm sampling interval. A 1 cm cell path was used. The samples were prepared with ∼100 µM peptide in water. The pH values of the solutions were adjusted to pH 7.4 or 6.5 using 0.1 M NaOH or HCl.
Electron Paramagnetic Resonance (EPR). All samples were prepared with degassed buffer containing 25 mM 3-(N-morpholino)propanesulfonic acid (MOPS) and 30% glycerol (v/v) where the glycerol served as a cryoprotectant. Samples were adjusted to pH 7.4 with HCl and/or KOH. X-band spectra (frequency of 9.43 GHz, microwave power in the range 0.6-5.0 mW, modulation amplitude of 5.0 G) were acquired at approximately 125 K using a Bruker EleXsys 500 spectrometer and an SHQ (Bruker) cavity equipped with a variable temperature controller. X-band spectra were analyzed in the manner described by Peisach and Blumberg. Table 2 .
The numbers of protons exchanged (Table 3) are determined from the binding enthalpies of Cu 2+ to the peptides in PIPES, The top panels show the differential power signal measured for each injection throughout the experiment, and the bottom panels show the integrated peak areas corresponding to the measured heat released per injection. The theoretical fit is superimposed on the data, and the resulting parameters are listed in Table 2. HEPES, TEEN, and Chol buffer solutions under identical experimental conditions. The enthalpy, ∆H, was determined by fitting ITC data using previously developed methods in which the competition of glycine binding to Cu 2+ is explicitly taken into account. 29, 30 These tabulated binding enthalpies are therefore only sensitive to the nature of the binding site(s) and the proton exchanged between peptide and buffer upon the association of Cu 2+ to the peptide. For the overall reaction the enthalpy determined by ITC is given by where ∆H Cu-A is the enthalpy for Cu 2+ binding to A as and ∆H buff is the enthalpy of buffer ionization for the reaction Thus, n H+ can be determined from the slope of a plot of ∆H vs ∆H buff ( Figure 2 ).
As shown in Table 3 , A (40) and A (16) of both human and rat species have the same binding enthalpies and numbers of protons exchanged, indicating the intermediate coordinating spheres are the same for the two peptides. This result is consistent with previous EPR and XANES studies. 24, 27 The binding constant to A (40) is a factor of ∼2 smaller than that for A (16) for both human and rat peptides. Because the enthalpy of binding is the same, this must reflect entropic effects, and is consistent with the different conformational changes of A (40) and A (16) upon Cu 2+ binding reflected in the reported FTIR data. 24 In summary, the thermodynamic and spectroscopic data indicate a common coordination sphere for Cu 2+ binding to A (40) and A (16) .
Cu 2+ Binding to Mutants of Human A (16). Mutant peptides were prepared to examine the roles of His6, His13, His14, Tyr10, and the N-terminus amine in Cu 2+ binding to the human A (16) peptide. Table 4 lists the binding constants, enthalpies, and numbers of protons exchanged of Cu 2+ binding to the peptides. (Table S1 of the Supporting Information provides the binding enthalpies in the four buffers used.) Figure  3 shows two examples of the titration curves and associated fits for the H6A and Ac-N peptides in PIPES buffer. The mutation of His6, His13, and His14 or the modification of N-terminus amine all have effects on Cu 2+ binding of human A (16) ( Table 4 and Supporting Information). Y10F, on the other hand, has few effects on the binding enthalpies and results in a small decrease of binding constants.
Compared to the natural peptide, acylation of the N-terminus amine of human A (16) (Ac-N) results in a ∼30-fold decrease in Cu 2+ binding affinity (Table 4 and Figure 3 ), clearly indicating the involvement of N-terminus amine for the Cu 2+ coordination. Single point mutations of each of the three histidine residues by Ala (HxA, x ) 6, 13, 14) also result in the reduced binding affinity of the peptide for Cu 2+ , and changes in the associated binding enthalpy. H6A results in the largest decrease of binding constants of the three HxA mutants, exhibiting a ∼3-fold decrease in Cu 2+ binding affinity (1.0 × 10 9 M -1 , Table 4 ). This is consistent with a recent report on the binding of Cu 2+ to the same three mutants of A (28) . 32 The thermodynamic data clearly suggest that N-terminus amine, His6, His13, and His14 are all involved in coordinating Cu 2+ ions and thereby 4N a Buffer ionization heats, ∆H buff , are also listed (NIST). All values are reported as kcal/mol. The number of protons transferred, n H+ (error < (0.1) for the binding of Cu 2+ to the peptides is determined from the slope of a plot of ∆H as a function of ∆H buff ( Figure 2 ). The binding enthalpies for all other peptides studied in the four buffers can be found in Table S1 of the Supporting Information. 
contribute to the coordination. To achieve a Cu 2+ coordination sphere with the established 3N1O coordination sphere at physiological pH, 4,5,9,19,21,22,24-27 there must be two or more 3N1O binding spheres present in equilibrium, consistent with the observed two types of Cu 2+ EPR signals. 4, 5, 9, 19, 32 The significant change by the modification of N-terminus amine clearly indicates the N-terminus amine is bound to Cu 2+ in the native peptide. Because of the significant difference in Gibbs energies between Cu 2+ binding to the natural peptide and the Ac-N mutant, we conclude that all 3N1O binding geometries present share the feature that the N-terminus amine group is one of the N ligands. This conclusion is also supported by previous findings that the spectroscopic properties (UV-vis, CD, and EPR) of the complex of Cu 2+ and N-terminus acetylated peptides differ significantly from those of unmodified peptide. 4, 5 The similar binding enthalpies and numbers of protons released for Cu 2+ coordination to Y10F and the human native peptide, Tyr10, can be ruled out as a potential ligand. This is in agreement with previous spectroscopic studies. 4, 5, 23, 27 However, the current work does not provide any insight into the identity of the O-ligand, and so cannot distinguish between the proposed COO -of Asp1 so that part of the coordination shell does not contribute to n H+ . The binding of Cu 2+ to N-terminus amine and the imidazole ring of histidine releases ∼0.6 and ∼0.2 protons at pH 7.4 and 37°C, respectively (the pK a data used to determine these values is provided in the Supporting Information). Thus, a 3N coordination sphere comprised of the N-terminus and two imidazole nitrogens would result in n H+ ) 1.0, significantly less than that observed (1.5) for the binding of Cu 2+ to human A (16) . To obtain n H+ ) 1.5 protons and have an overall 3N1O binding geometry for human A (16), Cu 2+ coordination must therefore involve other residues that release proton(s).
Consider the involvement of an amide N, which has been invoked for other proteins and peptides. [33] [34] [35] [36] [37] [38] The binding of Cu 2+ to an amide N will release 1.0 proton at pH 7.4, 37°C. If the 3N in the Cu 2+ coordination sphere were assigned to the N-terminus amine, imidazole, and amide N, then we would predict n H+ ) 1.8, which is greater than that observed experimentally for human A (16). These two cases, however, represent the only possible 3N coordinations, and so we conclude that there must be equilibrium between these two structures: {NH 2 gives n H+ ) 1.8 for H6, H13, or H14 and n H+ ) 1.0 for H6H13, H6H14, and H13H14, the experimental range observed (1.5-1.9) for the peptides studied reflects differences in the equilibria between these possible coordination spheres. The reaction enthalpy in PIPES buffer at 37°C of HxHy is ∼8-9 kcal/mol more negative than that for Hx at pH 7.4 and is ∼6 kcal/mol more negative than that for Hx at pH 6.5 (Supporting Information). This difference in binding enthalpies together with determined values for n H+ serve as constraints for determining the equilibrium populations of different coordination spheres.
The isotherms (Figures 1 and 2) reported herein have the characteristic shape of a single binding site, and thus, the multiple coordination spheres present are in fast equilibrium. The relative proportions of these different coordination spheres can then be determined as follows. The binding constant determined by ITC (K) is an apparent binding constant represented by the following sum of the possible complexes present: The top panels show the differential power signal measured for each injection throughout the experiment, and the bottom panels show the integrated peak areas corresponding to the measured heat released per injection. The theoretical fit is superimposed on the data, and the resulting parameters are listed in Table 4. where "i" refers to the contributing coordination sphere (e.g., H6, H6H14, etc.) and K i is its binding constant. Correspondingly, the enthalpy ∆H and the number of protons n H+ released are also averaged and can be expressed by where H i and (n H+ ) i are the enthalpy of and the number of protons released for the ith coordination sphere, respectively. With these equations, we can thereby relate the properties of individual coordinations to the resolved data by ITC.
We note that the HxA or HxAHyA mutants and human A exhibit similar Cu 2+ binding behavior. The EPR spectra of H13A and H14A contained two components and are similar to those of human A (16). 4, 9, 32 We find the EPR spectra of H6AH13A, H6AH14A, and H13AH14A are characterized by A | ∼160-163 G and g | ∼2.21-2.22 (Table 5) , which are also in the range reported for component II (prevalent at high pH) in human A . 4, 5, 9, 19 In addition, we found that (1) the two human mutants H13A and H13R have the same binding properties, (2) rat H14A has the same binding properties as rat A (16), indicating His6 is the dominant coordinating histidine, and (3) human mutant H6AH13A and rat H6A (R5G H6A Y10F H13R compared to human sequence) have the same binding properties. These data suggest that if the mutated amino acid is not a coordinating ligand itself, or not immediately adjacent to a coordinating amide bond, negligible effects on the binding thermodynamics are observed. We therefore conclude that HxA or HxAHyA and human A (16) all possess a common 3N1O coordination sphere. With this knowledge, we are able to determine the equilibrium between different potential Cu 2+ coordination through analysis of the thermodynamic parameters of the set of A (16) mutants.
The detailed analysis using eqs 1 and 2, the estimated number of protons released and binding enthalpy for HxHy, to determine the equilibrium concentrations of contributing coordination spheres is presented in the Supporting Information. In brief, the thermodynamics of Cu 2+ coordinated in the H6, H13, or H14 geometries are determined using the mutants H13AH14A, H6AH14A, and H6AH13A, respectively. For these three double histidine mutants, only one histidine is present in the peptide. The thermodynamics of Cu 2+ coordinated in the H6H13, H6H14, or H13H14 geometries are determined using the mutants H14A, H13A, and H6A, respectively. In these single histidine mutants, however, there are also potential contributions from Hx as well as HxHy. Table 6 presents the resulting thermodynamic parameters (K, ∆H, n H+ ) associated with each of the possible contributing coordination spheres at pH 7.4. There are several interesting observations to be made about the data in Table 6 . First, although coordinations H13 and H14 are more enthalpy-favored (more negative binding enthalpies) than H6, the Cu 2+ binding constant for H6 is about 3 times higher than those for H13 and H14. H6 is more entropy-favored, which is reasonable because His6 is closer to the N-terminus and therefore requires less conformational rearrangements of the peptide to form the coordination sphere of Cu 2+ relative to His13 or His14. Second, the calculated binding enthalpies for H6H13, H6H14, and H13H14 are similar (-9.4 to -12.6 kcal/mol) and in good agreement with our estimated enthalpies, -10 to -12 kcal/mol for HxHy coordinations. Third, the numbers of protons exchanged of H6H13, H6H14, and H13H14 are 1.1-1.2, which is also in good agreement with our estimations of ∼1.1-1.2 protons released for the formation of HxHy.
CD spectra of H13AH14A, H6AH14A, H6AH13A H6A, H13A, H14A, and human A (16) with the presence of Cu 2+ support the above conclusions (Figure 4) . The CD band for H13AH14A is centered at 590 nm, which is consistent with previously reported 588-590 nm for the coordinations {NH 2 , CO, N -, N Im His6 } (H6) in human A (1-6) or A (1-10) where only one histidine (His6) is present. 19 The CD bands for H6AH14A and H6AH13A are the same and centered at ∼610 nm, which is consistent with the similar thermodynamic properties observed for the two peptides. The small red shift (20 nm) of the CD band and lack of the positive signals at 650-700 nm of H6AH13A or H6AH14A compared to that of H13AH14A is likely due to the different positions of the histidines in the sequences, resulting in different chelating loops around the coordinated Cu 2+ . The spectra of H13A and H14A are similar and resemble that of H13AH14A (H6 coordination) but differ from that of H6AH13A (H14 coordination) or H6AH14A (H14 coordination), confirming our earlier conclusion of the ubiquitous involvement of His6 in Cu 2+ binding and that H6 is the only Hx coordination in H13A or H14A. The CD band of human A (16) also resembles that of H13AH14A, indicating the H6 is the only Hx coordination in human A (16). Given that His6 is involved in all coordination spheres present in the equilibrium mixture, the possible contributing species are restricted to H6, H6H13, and H6H14. Using the thermodynamic parameters derived for each of these structures (Table 6 ), the apparent binding constant for the human peptide is calculated to be (1.6 + 1.0 + 0.5) × 10 9 M -1 ) 3.1 × 10 9 M -1
. Calculation using eq 2 results in an apparent binding enthalpy of -6.1 kcal/ mol and the number of protons released as 1.5. These calculated parameters are in excellent agreement with the experimental results (K as 3.0 × 10 9 M -1 , ∆H as -5.6 kcal/mol, and n H+ as 1.5). We therefore conclude there is an equilibrium between three coordination spheres for human A (16): H6, H6H13, and H6H14, present in relative amounts 0.5:0.3:0.2 at pH 7.4 according to the binding constants. Now consider Cu 2+ binding to human A (16) at pH 6.5 (Table 7) . At pH 6.5, the binding constant of H6 coordination is 1.3 × 10 7 M -1 , ∼2 orders of magnitude smaller than that at pH 7.4. The binding constant at pH 6.5 can be calculated from the value at pH 7.4. Specifically, the value at pH 6.5 is that at pH 7.4 multiplied by the ratio of (1/(1 + 10 (pK a -pH) )) N-terminus × (1/(1 + 10 (pK a -pH) )) His6 × (1/(1 + 10 (pK a -pH) )) N -at pH 6.5 and 7.4. Taking the pK a of N-terminus amine, imidazole of His6, and amide N to be 7.6, 6.8, and 12 (Supporting Information), we find the binding constant at pH 6.5 is lower than that at pH 7.5 by a factor of ∼100, in excellent agreement with the experimental results. The binding enthalpy of H6 coordination is 1.0 kcal/mol, which is ∼3 kcal/mol more than that at pH 7.4. This is expected because there is more proton dissociation from the N-terminus and imidazole upon the formation of H6 coordination at pH 6.5.
Carrying out the same calculations as we did for mutants at pH 7.4, the binding constant and enthalpy at pH 6.5 are 6.7 × 10 7 M -1 and -3.9 kcal/mol for coordination H6H13 and 3.8 × 10
7 M -1 and -3.3 kcal/mol for coordination H6H14. The binding enthalpies are close to our estimations for the binding enthalpy of HxHy coordinations as -5 kcal/mol (Supporting Information). Using the proportionality factor, the ratio of ((1/ (1 + 10 (pK a -pH) )) N-terminus × (1/(1 + 10 (pK a -pH) )) His6 × (1/(1 + 10 (pK a -pH) )) His13/His14 ) of pH 6.5 and pH 7.4, the binding constants of H6H13 and H6H14 at pH 6.5 are ∼1/15 of that at pH 7.4, which are also in excellent agreement with the experimental data. Moreover, H6, which releases more protons than H6H14 and H6H13, should become less dominant with decreasing solution pH. Consistent with this prediction, the binding constants of peptides studied at pH 6.5 indicate that H6 accounts for ∼10% of the Cu 2+ coordinations of human A (16), smaller than that at pH 7.4 (50%). In summary, the collective set of ITC data, CD data, and EPR data of human A (16) and its mutants establishes that the binding of Cu 2+ to the human A (16) peptide involves three distinctive binding coordination spheres present in equilibrium: H6, H6H13, and H6H14 over the pH range we studied (6.5-7.4) (Scheme 1a). The relative concentrations for H6:H6H13:H6H14 are 0.5:0.3:0.2 and 0.1: 0.6:0.3 at pH 7.4 and 6.5, respectively.
We now consider this result in the context of previous works. Previous ESR studies resulted in the conclusion that there are two types of binding structures, with one dominant at pH <7 and the other dominant at pH >10. 5 The binding mode {NH 2 , N Im 6 , N Im 13 , N Im 14 } was proposed to be dominant at neutral pH, and the possible involvement of amide NH was suggested for the mode at higher pH. Recently, the same group suggested coordination spheres { NH 2 , COO -, COO -, N Im 6 , N Im 13 , N Im 14 } involving all three histidines (His6, His13, and His14) and two O-ligand and N-terminus, for both structures, with the Nterminal amino group as an axial ligand at pH 7.4 but in plane at pH 9.0. 32 These two modes release the same numbers of protons (∼1.4 protons), and therefore must have the same pH dependence. However, the EPR spectra reported vary with pH, a suggestion that this assignment is unlikely.
Two N-His6,13,14 labeled A (16) are the same. This inconsistency is likely due to different normalization. Thus, the assignment of component II needs further confirmation. We also note that, for the proposed component II, the binding of Cu 2+ to the peptide would release fewer protons compared to component I (at pH <8). Thus, with increasing pH, component I would become dominant, not component II as suggested by the work. Moreover, the EPR parameters of component II are close to the values for a CuL species of human A (16) that releases ∼2 protons upon its formation 4 or that obtained for mutants H6AH13A, H6AH14A, or H13AH14A of human A (16) in this current work. These observations indicate that component II is indeed Hx coordination geometry. We suggest that, although extremely low temperature could possibly shift the equilibrium, it is likely that H6 is the component II detected in the EPR spectra at pH 8. 9 With this information, the earlier study actually reveals the same three coordination spheres as concluded herein.
Potentiometric studies suggested that Cu 2+ bound with human A (16 or 28) is almost equally distributed between two types a The calculated parameters of the H6H13 and H6H14 complexes are also listed.
b Due to the contribution of {NH 2 , COO -, N Im }, the binding constant of H6 is about 80% of that for H13AH14A and the enthalpy is about 0.6 kcal/mol more than H13AH14A. See the Supporting Information for details.
of binding geometries at physiological pH (7.4), CuHL assigned as {NH 2 , COO -, N Im 13 , N Im 14 } and CuL assigned as {NH 2 , CO, N -, N Im } (for the latter geometry, His6 was proposed to dominate as the origin of N Im ). 4, 19 Our data indicated H6 accounts for 50% of the bound Cu 2+ , with H6H13 and H6H14 accounting for the other 50%. This observation is consistent with potentiometric data except that the conclusion that two N Im of CuHL complex are from His13 and His14. 4 However, no specific evidence was provided to support this assignment in that work. This assignment was likely based on the fact that the coordination is only present in A (16) but not present in A (1-6) or A (1-10) where His13 and His14 are absent. Our ITC data shows that the binding constant of H13H14 is ∼0.4 × 10 9 M -1 , only ∼10% of that for human A (16). Thus, if it is the {NH 2 , O, N Im , N Im } component, this mode can only possess ∼10% of the bound Cu 2+ , which is much lower than the detected 50% and excludes the assignment. Cu 2+ Binding to Rat A (16). The rat A wildtype sequence possesses an Arg at position 13 and thus cannot coordinate here through His as observed in the human sequence. Thus, by taking an analogue to human A (16), there are only two possible coordination spheres, H6 and H6H14. Table 8 lists the binding constants, enthalpies, and numbers of protons associated with Cu 2+ binding to the mutant of rat A (16): rat H6A and rat H14A at pH 7.4. Rat A (16) and rat H14A mutant exhibit nearly identical Cu 2+ binding parameters at pH 7.4. The Cu 2+ binding properties of rat H6A, where only His14 is present, are similar to the human H6AH13A or H6AH14A mutant, suggesting Y10F, R5G, and H13R have negligible effects on the H14 or H13 coordination sphere. The CD spectra of rat A (16) loaded with Cu 2+ are also similar to those of rat H14A mutants, while the CD of rat H6A mutant is similar to that of human H6AH13A and H6AH14A ( Figure 5 ). The similar Cu 2+ binding thermodynamics and spectroscopic properties of rat A (16) and rat H14A clearly establish His6 as the dominant histidine bound to Cu 2+ . The binding enthalpy and n H+ for Cu 2+ to rat A (16) or rat H14A at pH 7.4, 37°C, are -4.0 kcal/mol and 1.8, respectively. n H+ is the same as we estimated for Hx coordination. The enthalpy is close to the observed binding enthalpies to Hx in human sequence as -2 to -3 kcal/mol. Thus, we conclude that H6 is the dominant coordination for both rat A (16) and rat H14A at pH 7.4.
If we assume that the three mutations of rat sequence (R5G, Y10F, and H13R) have little effect on H6H14, which is reasonable because the amide N of His6 (next to Arg5) or His14 (next to His13) is not involved in binding for this coordination, the Cu 2+ binding constant of rat H6H14 is close to 0.6 × 10 9 M -1 , the value for human sequence. This value however is on the order of the error in our measurements of the binding constant (∼10 × 10 9 ( 10 9 M -1
), and so we cannot unambigu- ously determine whether H6H14 contributes to Cu 2+ binding in the rat peptide at pH 7.4. However, if H6H14 is present, it represents only ∼6% of the total concentration. Thus, in the rat peptide at pH 7.4 and 37°C, H6 is the dominant coordination sphere (∼94%) with a potential minor contribution from H6H14 (∼6%) (Scheme 1b).
The binding constants, enthalpies, and numbers of protons associated with Cu 2+ binding to rat A (16) and rat H14A at pH 6.5 in PIPES buffer are determined and listed in Table 9 . The Cu 2+ binding constants of rat H14A (rat H6) at pH 6.5 are ∼2 -orders of magnitude smaller than that at pH 7.4. As previously discussed, the binding constant of Hx at pH 6.5 is ∼1/100 of that at pH 7.4. The experimental data is in excellent agreement with this calculation. Rat A (16) has a slightly larger binding constant than that of rat H14A, but the difference (2 × 10 7 M -1 ) is on the order of the error in determining binding constants over 1 × 10 8 M -1 . However, different from the data at pH 7.4, rat H14A has less negative binding enthalpies (-0.1 kcal/mol) than rat A (16) (-0.8 kcal/mol), which clearly indicates a possible contribution of H6H14 in rat A (16) . Because the difference between rat A (16) and rat H14A (2 × 10 7 M -1 ) is about the level of error for determining binding constants over 1 × 10 8 M -1 , a pretty large error may exist in determining the binding constant of rat H6H14 this way. The binding constant of H6H14 of human A (16) at pH 6.5 is ∼3.8 × 10 7 M -1 , which is close to the observed difference between rat A (16) and rat H14A. Thus, we suggest the binding constant of H6H14 in rat A (16) in the range (2-4) × 10 7 M -1 . The binding enthalpy for this mode is estimated to be -4 to -2.3 kcal/mol, which is close to the value for H6H14 in human A (16) as -3.3 kcal/mol and also in good agreement with the estimated binding enthalpy for HxHy as ∼ -5 kcal/mol. These analyses support that the presence of H6H14 (20-30% according to binding constants) contributes to the more negative binding enthalpies in rat A (16) as compared to that of rat H14A at pH 6.5.
The proposed coordination for rat A (16) at pH 7.4 is consistent with earlier work, which showed that Cu 2+ bound with rat A (16) is dominantly in form CuL with only one histidine involved as {NH 2 , COO -, N -, N Im } (H6 coordination). 4, 19 However, it differs from a recent study suggesting a coordination as {NH 2 , 2N Im } with both His6 and His14 of rat A (28) serving as anchoring sites for Cu 2+ . 39 However, to mitigate the aggregation of the peptide, those experiments were conducted in micellar solutions with sodium dodecyl sulfate (SDS). SDS induces the peptide to form an R-helix, and thus in the presence of the surfactant, the peptides is in a different configuration. 39 The energetics of Cu 2+ binding, therefore, depends on whether SDS is present in solution, and it is not surprising to obtain different binding modes when SDS is present.
Comparison of Cu 2+ Binding to Human and Rat A . The thermodynamic and spectroscopic analyses establish that there are three coordination spheres, H6, H6H13, and H6H14, in human A (16) and two, H6 and H6H14, in rat A (16) (Scheme 1). The thermodynamic properties for Cu 2+ to H6H14 are similar for human and rat A (16), while the properties for Cu 2+ to H6 are quite different for the two peptides. Rat H6 exhibits approximately 6 times the affinity for Cu 2+ as the human H6 and releases less heat. This must be related to the amino acid difference between the two species. As mentioned in the Introduction, the rat and human peptides differ by three amino acidssR5G, Y10F, and H13R. In order to determine whether a single mutation causes the different Cu 2+ binding thermodynamics between rat and human A peptides, we examined peptides containing each of the three individual mutations.
The binding constants, enthalpies, and numbers of protons exchanged of Cu 2+ binding to those mutants at pH 7.4 are listed in Table 10 . The mutations Y10F and H13R result in a decreased Cu 2+ binding constant. For Y10F, the enthalpies of binding are similar to those of the native human peptide in the four buffers we studied. The reduction in Cu 2+ binding constant by H13R is similar to that observed for H13A. On the other hand, R5G mutant exhibits the same binding constant, binding enthalpy, and numbers of protons released as the native rat peptide. The mutation R5G reproduces quantitatively the difference in Cu 2+ binding thermodynamics between human and rat A (16) at pH 7.4. This conclusion is further confirmed by CD studies. Figure  5 showed visible CD spectra of human A (16), rat A (16), and R5G in the presence of CuCl 2 at pH 7.4. The d-d transition band of human A (16) is centered at 570 nm, ∼100 nm shorter than that of rat A (16) (670 nm). These data are consistent with previously reported CD spectra of the two peptides. 4 The CD spectrum of R5G mutant resembles that of rat A (16), supporting that R5G is responsible for the coordination difference between human and rat H6. It has been suggested that human and rat H6 coordinations contain the amide of Ala2 and His6, respectively. 4, 19 The decreased bulkiness and positive charges that result from the R5G mutation enable formation of a stable six-member chelation ring (by His6, amide N, and Cu the extent of Cu 2+ -induced aggregations of human A (40), rat A (40), and single mutation on human A (40): R5G(40) at pH 7.4 and 6.5 after incubation at 37°C for 0.5 h. The presence of Cu 2+ significantly increases the aggregation of human A (40), but this effect is much less profound for rat A (40). The Cu 2+ -induced aggregations of human A (40) are pH-dependent, more profound at pH 6.5 than pH 7.4. These results on human and rat A (40) at pH 7.4 and 6.5 are consistent with the reported data. 12 The R5G mutation reduced Cu 2+ -induced aggregations to the same levels as rat A (40). For the experimental conditions of this assay (∼20 µM Cu 2+ and 2.5 µM A (40)), more than 99.9% of all three peptides studied are loaded with Cu 2+ , since their Cu 2+ binding constants are 10 9 -10 8 M -1 at pH 7.4-6.5. Combining the fact that R5G(40) shares the same coordinations as rat A (40) and has the same level of Cu 2+ -induced aggregation as rat A (40), we conclude it is the difference between binding sites rather than the amount of bound Cu 2+ between the rat and human peptide that influences the aggregation process.
By examining the pH dependence of coordinations and pH dependence of the Cu 2+ -induced aggregation, we observed an interesting positive correlation between the proportions of coordination H6H13 and H6H14 and the degree of aggregations. For example, in the rat peptide, H6 is the dominant coordination sphere (∼94%) with a possible minor contribution from H6H14 at pH 7.4. In the human peptide, there are three Cu 2+ coordinations in equilibrium: H6 (50%), H6H13 (30%), and H6H14 (20%) at pH 7.4. Human A (16) formed more aggregates than rat A (16) at pH 7.4. When the solution pH is changed from 7.4 to 6.5, increased percentage of bound Cu 2+ is in the form of H6H13 and H16H14 in human A (16) and in the form of H6H14 in rat A (16) . Accordingly, we observed increased Cu 2+ -induced aggregation at pH 6.5. The correlation indicates that the formation of H6H13 or H6H14 induces more aggregation than H6.
Compared to H6, the formation of H6H13 and H6H14 coordination spheres requires greater conformational rearrangements, which is reflected by their larger negative binding enthalpies but smaller binding constants. The conformational change resulting from the formation of H6H13 or H6H14 must play an important role in the Cu 2+ -induced aggregation of A . On the basis of the aggregation assay on human A (40), rat A (40), and R5G(40), we conclude that the equilibrium between Cu 2+ coordinations can greatly affect Cu 2+ -induced A aggregation and that the conformational changes that accompany the formation of H6H13 and H6H14 coordination induce more or accelerate more of the Cu 2+ -initiated aggregation of the A peptide than that accompanying H6.
Conclusions
CD, EPR, and ITC studies on the coordination for Cu 2+ to human and rat A reveal that at pH 7.4, 37°C, and 0.16 M ionic strength there are three Cu 2+ coordination spheres for human A (16) and one dominant coordination sphere for rat A (16) The proportion of these coordination spheres varies with solution pH. Human and rat A differ in three amino acids (R5G, Y10F, and H13R), and R5G is responsible for the difference of Cu 2+ coordinations between the two species. In addition, this single mutation of human A (40) reduces Cu 2+ -induced aggregation of the peptide to the level of that for rat A (40). 
